Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bagherzadeh
Ebrahim Bagherzadeh, Sugarland, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080281136 | CATALYST AND METHOD FOR CONVERTING NATURAL GAS TO HIGHER CARBON COMPOUNDS - A catalyst composition and process facilitates the oxidative reforming of low molecular weight hydrocarbons, such as methane, to other hydrocarbons having 2 or more carbon atoms (“C | 11-13-2008 |
Ebrahim Bagherzadeh, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120136075 | SYSTEM AND PROCESS FOR FISCHER-TROPSCH CONVERSION - A system for converting carbon monoxide and hydrogen gas into C2+ hydrocarbons including at least one high shear mixing device comprising at least one rotor and at least one stator separated by a shear gap, wherein the high shear mixing device is capable of producing a tip speed of the at least one rotor of greater than 22.9 m/s (4,500 ft/min), and a pump configured for delivering a fluid stream comprising liquid medium to the high shear mixing device. | 05-31-2012 |
Mehran Seid Bagherzadeh, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20090270394 | CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted cyclylamine derivatives as shown in formulas (1). | 10-29-2009 |
| 20100125072 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 05-20-2010 |
| 20100173967 | USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS - This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R | 07-08-2010 |
| 20110034500 | SPIROHETEROCYCLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiroheterocyclic compounds of formula (I): | 02-10-2011 |
| 20110172282 | USE OF SPIRO-OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS - This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R | 07-14-2011 |
| 20120035199 | SPIROHETEROCYCLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiroheterocyclic compounds of formula (I): | 02-09-2012 |
Mehran Seid Bagherzadeh US
| Patent application number | Description | Published |
|---|---|---|
| 20100130487 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 05-27-2010 |
| 20110251224 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 10-13-2011 |
| 20120122909 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to spiro-oxindole compounds of formula (I): | 05-17-2012 |
Mehran Seid Bagherzadeh, North Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20090131447 | COMBINATION THERAPY - This invention is directed to the use of SCD-1 inhibitors of the formula (I): where x, y, V, W, G, J, L, M, R2, R3, R5, R5a, R6, R6a, R7, R7a, R8 and R8a are defined herein, in combination with other drug therapies to treat adverse weight gain. | 05-21-2009 |
| 20100048584 | PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS - Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): | 02-25-2010 |